FORTE BIOSCIENCES INC (FBRX) Fundamental Analysis & Valuation

NASDAQ:FBRX • US34962G2084

Current stock price

25.78 USD
+0.17 (+0.66%)
Last:

This FBRX fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

1

1. FBRX Profitability Analysis

1.1 Basic Checks

  • FBRX had negative earnings in the past year.
  • FBRX had a negative operating cash flow in the past year.
  • In the past 5 years FBRX always reported negative net income.
  • FBRX had a negative operating cash flow in each of the past 5 years.
FBRX Yearly Net Income VS EBIT VS OCF VS FCFFBRX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 -20M -40M -60M

1.2 Ratios

  • FBRX has a Return On Assets of -53.29%. This is comparable to the rest of the industry: FBRX outperforms 46.24% of its industry peers.
  • FBRX has a Return On Equity of -61.53%. This is comparable to the rest of the industry: FBRX outperforms 57.61% of its industry peers.
Industry RankSector Rank
ROA -53.29%
ROE -61.53%
ROIC N/A
ROA(3y)-56.48%
ROA(5y)-59.11%
ROE(3y)-63.42%
ROE(5y)-64.27%
ROIC(3y)N/A
ROIC(5y)N/A
FBRX Yearly ROA, ROE, ROICFBRX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 -100 -200 -300 -400 -500

1.3 Margins

  • The Profit Margin and Operating Margin and Gross Margin are not available for FBRX so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
FBRX Yearly Profit, Operating, Gross MarginsFBRX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 -50K -100K -150K

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

8

2. FBRX Health Analysis

2.1 Basic Checks

  • FBRX has more shares outstanding than it did 1 year ago.
  • Compared to 5 years ago, FBRX has more shares outstanding
  • FBRX has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
FBRX Yearly Shares OutstandingFBRX Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M
FBRX Yearly Total Debt VS Total AssetsFBRX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

2.2 Solvency

  • FBRX has an Altman-Z score of 11.16. This indicates that FBRX is financially healthy and has little risk of bankruptcy at the moment.
  • The Altman-Z score of FBRX (11.16) is better than 83.04% of its industry peers.
  • There is no outstanding debt for FBRX. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 11.16
ROIC/WACCN/A
WACCN/A
FBRX Yearly LT Debt VS Equity VS FCFFBRX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M -40M 60M

2.3 Liquidity

  • A Current Ratio of 7.34 indicates that FBRX has no problem at all paying its short term obligations.
  • The Current ratio of FBRX (7.34) is better than 70.33% of its industry peers.
  • A Quick Ratio of 7.34 indicates that FBRX has no problem at all paying its short term obligations.
  • FBRX has a Quick ratio of 7.34. This is in the better half of the industry: FBRX outperforms 70.71% of its industry peers.
Industry RankSector Rank
Current Ratio 7.34
Quick Ratio 7.34
FBRX Yearly Current Assets VS Current LiabilitesFBRX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

1

3. FBRX Growth Analysis

3.1 Past

  • FBRX shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 71.06%, which is quite impressive.
EPS 1Y (TTM)71.06%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%78.19%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • Based on estimates for the next years, FBRX will show a quite strong growth in Earnings Per Share. The EPS will grow by 11.00% on average per year.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y75.3%
EPS Next 2Y33.54%
EPS Next 3Y20.68%
EPS Next 5Y11%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
FBRX Yearly Revenue VS EstimatesFBRX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2028 2029 2030 2031 2032 2033 200M 400M 600M
FBRX Yearly EPS VS EstimatesFBRX Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 0 -500 -1K -1.5K -2K

More info and screens

Find the best growth stocksShow best growing peers

1

4. FBRX Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for FBRX. In the last year negative earnings were reported.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for FBRX. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
FBRX Price Earnings VS Forward Price EarningsFBRX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
FBRX Per share dataFBRX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4 -4 6

4.3 Compensation for Growth

  • A more expensive valuation may be justified as FBRX's earnings are expected to grow with 20.68% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y33.54%
EPS Next 3Y20.68%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. FBRX Dividend Analysis

5.1 Amount

  • FBRX does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

FBRX Fundamentals: All Metrics, Ratios and Statistics

FORTE BIOSCIENCES INC

NASDAQ:FBRX (3/24/2026, 11:29:54 AM)

25.78

+0.17 (+0.66%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)11-14
Earnings (Next)03-26
Inst Owners90.58%
Inst Owner Change18.7%
Ins Owners1.08%
Ins Owner Change2.35%
Market Cap323.02M
Revenue(TTM)N/A
Net Income(TTM)-51.74M
Analysts83.33
Price Target55.9 (116.83%)
Short Float %6.57%
Short Ratio3.33
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)12.05%
Min EPS beat(2)9.08%
Max EPS beat(2)15.02%
EPS beat(4)3
Avg EPS beat(4)2.31%
Min EPS beat(4)-41.38%
Max EPS beat(4)26.55%
EPS beat(8)6
Avg EPS beat(8)3.47%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)4.06%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 3.84
P/tB 3.84
EV/EBITDA N/A
EPS(TTM)-5.77
EYN/A
EPS(NY)-3.84
Fwd EYN/A
FCF(TTM)-3.54
FCFYN/A
OCF(TTM)-3.52
OCFYN/A
SpS0
BVpS6.71
TBVpS6.71
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -53.29%
ROE -61.53%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-56.48%
ROA(5y)-59.11%
ROE(3y)-63.42%
ROE(5y)-64.27%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 264.82%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 7.34
Quick Ratio 7.34
Altman-Z 11.16
F-Score6
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)71.06%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%78.19%
EPS Next Y75.3%
EPS Next 2Y33.54%
EPS Next 3Y20.68%
EPS Next 5Y11%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-49.22%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-95.09%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-95.06%
OCF growth 3YN/A
OCF growth 5YN/A

FORTE BIOSCIENCES INC / FBRX Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for FORTE BIOSCIENCES INC?

ChartMill assigns a fundamental rating of 3 / 10 to FBRX.


What is the valuation status for FBRX stock?

ChartMill assigns a valuation rating of 1 / 10 to FORTE BIOSCIENCES INC (FBRX). This can be considered as Overvalued.


What is the profitability of FBRX stock?

FORTE BIOSCIENCES INC (FBRX) has a profitability rating of 1 / 10.


Can you provide the financial health for FBRX stock?

The financial health rating of FORTE BIOSCIENCES INC (FBRX) is 8 / 10.